SCHEMBL10077585

SCHEMBL10077585

CCOC(=O)c1cccc2c1C(=O)CC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
CYP1A2 P05177 3/20 0.48
MAPT P10636 3/20 0.48
KMT2A Q03164 3/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
ALOX15 P16050 2/20 0.48
MEN1 O00255 2/20 0.48
USP2 O75604 2/20 0.48
CYP3A4 P08684 1/20 0.48
MAPK10 P53779 1/20 0.48
PTK2B Q14289 1/20 0.48
NCOA1 Q15788 1/20 0.48
NCOA3 Q9Y6Q9 1/20 0.48
ALDH1A1 P00352 5/20 0.47
HSD17B10 Q99714 2/20 0.47
KDM4E B2RXH2 4/20 0.45
HPGD P15428 2/20 0.45
CYP2D6 P10635 1/20 0.45
CLEC4M Q9H2X3 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14328265 0.84 TSHR (0.53) TSHRCYP1A2MAPTKMT2ACYP2C9
SCHEMBL11630902 0.77 ALDH1A1 (0.60) TSHRCYP1A2MAPTKMT2ACYP2C9
SCHEMBL14621014 0.75 TSHR (0.57) TSHRCYP1A2MAPTKMT2ACYP2C9
SCHEMBL11006532 0.75 TSHR (0.57) TSHRCYP1A2MAPTKMT2ACYP2C9
SCHEMBL2768852 0.74 TSHR (0.53) TSHRCYP1A2MAPTKMT2ACYP2C9
SCHEMBL7276418 0.74 TSHR (0.56) TSHRCYP1A2MAPTKMT2ACYP2C9
SCHEMBL3075856 0.74 TSHR (0.42) TSHRMAPTKMT2AMEN1MAPK10
Diethyl Phthalate SCHEMBL22296 0.72 TSHR (1.00) TSHRCYP1A2MAPTKMT2ACYP2C9
Diethyl Phthalate SCHEMBL29404255 0.72 TSHR (1.00) TSHRCYP1A2MAPTKMT2ACYP2C9
Diethyl Phthalate SCHEMBL5306972 0.72 TSHR (1.00) TSHRCYP1A2MAPTKMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120329842-A1 SMALL MOLECULE COMPOUNDS AS BROAD-SPECTRUM INHIBITORS OF METALLO-BETA-LACTAMASES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-12-27 US disclosed
US-20120329842-A1 SMALL MOLECULE COMPOUNDS AS BROAD-SPECTRUM INHIBITORS OF METALLO-BETA-LACTAMASES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-12-27 US disclosed
WO-2012088283-A1 SMALL MOLECULE COMPOUNDS AS BROAD-SPECTRUM INHIBITORS OF METALLO-BETA-LACTAMASES BAYLOR COLLEGE OF MEDICINE (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120329842-A1 SMALL MOLECULE COMPOUNDS AS BROAD-SPECTRUM INHIBITORS OF METALLO-BETA-LACTAMASES MGAM, MGAM2, BPGM TSHR 4586/4885CYP1A2 1395/4885MAPT 2904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.